celecoxib has been researched along with Coronavirus Infections in 2 studies
Coronavirus Infections: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib has properties that should be evaluated in randomized controlled studies and is also available for off-label use." | 2.66 | COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies. ( Aydin, SY; Baghaki, HS; Baghaki, S; Daghan, B; Yalcin, CE; Yavuz, E, 2020) |
| "Carprofen and Celecoxib have been selected by the COVID Moonshot initiative for in vitro testing; they show 3." | 1.56 | Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. ( Cereto-Massagué, A; Garcia-Vallvé, S; Gimeno, A; Macip, G; Mestres-Truyol, J; Ojeda-Montes, MJ; Pujadas, G; Saldivar-Espinoza, B, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gimeno, A | 1 |
| Mestres-Truyol, J | 1 |
| Ojeda-Montes, MJ | 1 |
| Macip, G | 1 |
| Saldivar-Espinoza, B | 1 |
| Cereto-Massagué, A | 1 |
| Pujadas, G | 1 |
| Garcia-Vallvé, S | 1 |
| Baghaki, S | 1 |
| Yalcin, CE | 1 |
| Baghaki, HS | 1 |
| Aydin, SY | 1 |
| Daghan, B | 1 |
| Yavuz, E | 1 |
1 review available for celecoxib and Coronavirus Infections
| Article | Year |
|---|---|
COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.
Topics: Celecoxib; Coronavirus Infections; COVID-19 Drug Treatment; Cyclooxygenase 2 Inhibitors; Drug Reposi | 2020 |
1 other study available for celecoxib and Coronavirus Infections
| Article | Year |
|---|---|
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition.
Topics: Antiviral Agents; Betacoronavirus; Binding Sites; Carbazoles; Celecoxib; Coronavirus Infections; COV | 2020 |